Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series.
Seçkin D, Barete S, Euvrard S, Francès C, Kanitakis J, Geusau A, Del Marmol V, Harwood CA, Proby CM, Ali I, Güleç AT, Durukan E, Lebbé C, Alaibac M, Laffitte E, Cooper S, Bouwes Bavinck JN, Murphy GM, Ferrándiz C, Mørk C, Cetkovská P, Kempf W, Hofbauer GF. Seçkin D, et al. Among authors: mork c. Am J Transplant. 2013 Aug;13(8):2146-53. doi: 10.1111/ajt.12281. Epub 2013 May 29. Am J Transplant. 2013. PMID: 23718915 Free article.
A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp.
Wiegell SR, Fabricius S, Stender IM, Berne B, Kroon S, Andersen BL, Mørk C, Sandberg C, Jemec GB, Mogensen M, Brocks KM, Philipsen PA, Heydenreich J, Haedersdal M, Wulf HC. Wiegell SR, et al. Among authors: mork c. Br J Dermatol. 2011 May;164(5):1083-90. doi: 10.1111/j.1365-2133.2011.10209.x. Epub 2011 Apr 5. Br J Dermatol. 2011. PMID: 21219287 Clinical Trial.
Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
Wiegell SR, Fabricius S, Gniadecka M, Stender IM, Berne B, Kroon S, Andersen BL, Mørk C, Sandberg C, Ibler KS, Jemec GB, Brocks KM, Philipsen PA, Heydenreich J, Hædersdal M, Wulf HC. Wiegell SR, et al. Among authors: mork c. Br J Dermatol. 2012 Jun;166(6):1327-32. doi: 10.1111/j.1365-2133.2012.10833.x. Br J Dermatol. 2012. PMID: 22250644 Clinical Trial.
Guidelines for practical use of MAL-PDT in non-melanoma skin cancer.
Christensen E, Warloe T, Kroon S, Funk J, Helsing P, Soler AM, Stang HJ, Vatne O, Mørk C; Norwegian Photodynamic Therapy (PDT) Group. Christensen E, et al. Among authors: mork c. J Eur Acad Dermatol Venereol. 2010 May;24(5):505-12. doi: 10.1111/j.1468-3083.2009.03430.x. Epub 2009 Oct 6. J Eur Acad Dermatol Venereol. 2010. PMID: 19807828 Review.
New, simplified versus standard photodynamic therapy (PDT) regimen for superficial and nodular basal cell carcinoma (BCC): A single-blind, non-inferiority, randomised controlled multicentre study.
Christensen E, Mørk E, Foss OA, Mørk C, Kroon S, Dotterud LK, Helsing P, Vatne Ø, Skogvoll E, Mjønes P, Bachmann IM. Christensen E, et al. Among authors: mork c. PLoS One. 2024 Mar 8;19(3):e0299718. doi: 10.1371/journal.pone.0299718. eCollection 2024. PLoS One. 2024. PMID: 38457386 Free PMC article. Clinical Trial.
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials.
Brun MK, Gehin JE, Bjørlykke KH, Warren DJ, Klaasen RA, Sexton J, Sandanger Ø, Kvien TK, Mørk C, Jahnsen J, Bolstad N, Jørgensen KK, Haavardsholm EA, Goll GL, Syversen SW. Brun MK, et al. Among authors: mork c. Lancet Rheumatol. 2024 Apr;6(4):e226-e236. doi: 10.1016/S2665-9913(23)00341-7. Epub 2024 Feb 22. Lancet Rheumatol. 2024. PMID: 38402891 Clinical Trial.
80 results